Kits Net Receivables vs Selling General Administrative Analysis

KITS Stock

CAD 8.67 0.01 0.12%

Kits Eyecare financial indicator trend analysis is infinitely more than just investigating Kits Eyecare recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kits Eyecare is a good investment. Please check the relationship between Kits Eyecare Net Receivables and its Selling General Administrative accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kits Eyecare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Receivables vs Selling General Administrative

Net Receivables vs Selling General Administrative Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kits Eyecare Net Receivables account and Selling General Administrative. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Kits Eyecare's Net Receivables and Selling General Administrative is -0.64. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of Kits Eyecare, assuming nothing else is changed. The correlation between historical values of Kits Eyecare's Net Receivables and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Kits Eyecare are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Net Receivables i.e., Kits Eyecare's Net Receivables and Selling General Administrative go up and down completely randomly.

Correlation Coefficient

-0.64

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Net Receivables

Selling General Administrative

Most indicators from Kits Eyecare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kits Eyecare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kits Eyecare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Kits Eyecare's Issuance Of Capital Stock is very stable compared to the past year. As of the 11th of December 2024, Sales General And Administrative To Revenue is likely to grow to 0.14, though Tax Provision is likely to grow to (642.2 K).

	2021	2022	2023	2024 (projected)
Interest Expense	1.5M	1.6M	1.6M	1.6M
Interest Income	67K	1.5M	585K	352.2K

Interest Expense Interest Income

Kits Eyecare fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Stockholder Equity	Total Liab	Total Current Assets	Cash And Equivalents	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Other Current Liab	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Currrent Assets Other	Long Term Debt	Capital Surpluse
Total Assets		0.82	0.9	-0.9	0.88	0.83	0.88	-0.71	-0.25	0.96	0.29	0.87	0.92	0.85	0.9	0.89	-0.71	0.91	-0.9	0.85	0.9	0.82	-0.86	0.88	-0.56	0.85
Total Current Liabilities	0.82		0.49	-0.62	0.44	0.52	0.44	-0.72	-0.74	0.66	-0.23	0.99	0.54	0.48	0.55	0.56	-0.56	0.61	-0.75	0.47	0.49	0.58	-0.51	0.52	-0.2	0.6
Total Stockholder Equity	0.9	0.49		-0.92	0.99	0.89	0.99	-0.5	0.19	0.96	0.64	0.56	0.99	0.93	0.95	0.93	-0.71	0.94	-0.8	0.95	0.99	0.85	-0.94	0.96	-0.76	0.86
Retained Earnings	-0.9	-0.62	-0.92		-0.9	-0.98	-0.9	0.53	-0.06	-0.95	-0.58	-0.66	-0.94	-0.98	-0.99	-0.99	0.89	-0.98	0.93	-0.97	-0.95	-0.93	0.99	-0.96	0.77	-0.99
Cash	0.88	0.44	0.99	-0.9		0.87	1.0	-0.5	0.23	0.94	0.65	0.53	0.99	0.92	0.94	0.92	-0.65	0.91	-0.79	0.95	0.99	0.8	-0.93	0.94	-0.71	0.84
Other Assets	0.83	0.52	0.89	-0.98	0.87		0.87	-0.46	0.16	0.9	0.68	0.56	0.9	0.98	0.98	0.98	-0.93	0.95	-0.85	0.97	0.91	0.93	-0.99	0.95	-0.85	0.99
Cash And Short Term Investments	0.88	0.44	0.99	-0.9	1.0	0.87		-0.5	0.23	0.94	0.65	0.53	0.99	0.92	0.94	0.92	-0.65	0.91	-0.79	0.95	0.99	0.8	-0.93	0.94	-0.71	0.84
Net Receivables	-0.71	-0.72	-0.5	0.53	-0.5	-0.46	-0.5		0.51	-0.59	0.03	-0.78	-0.52	-0.49	-0.55	-0.54	0.31	-0.46	0.61	-0.5	-0.54	-0.33	0.5	-0.42	0.11	-0.49
Common Stock Shares Outstanding	-0.25	-0.74	0.19	-0.06	0.23	0.16	0.23	0.51		0.0	0.77	-0.69	0.14	0.19	0.12	0.1	-0.04	0.07	0.18	0.21	0.19	0.09	-0.18	0.19	-0.41	0.06
Inventory	0.96	0.66	0.96	-0.95	0.94	0.9	0.94	-0.59	0.0		0.47	0.72	0.98	0.91	0.94	0.93	-0.78	0.97	-0.91	0.92	0.96	0.9	-0.93	0.96	-0.69	0.91
Other Stockholder Equity	0.29	-0.23	0.64	-0.58	0.65	0.68	0.65	0.03	0.77	0.47		-0.18	0.58	0.7	0.64	0.63	-0.54	0.55	-0.27	0.72	0.64	0.56	-0.69	0.66	-0.84	0.58
Total Liab	0.87	0.99	0.56	-0.66	0.53	0.56	0.53	-0.78	-0.69	0.72	-0.18		0.62	0.54	0.62	0.62	-0.54	0.65	-0.79	0.53	0.57	0.58	-0.57	0.56	-0.2	0.63
Total Current Assets	0.92	0.54	0.99	-0.94	0.99	0.9	0.99	-0.52	0.14	0.98	0.58	0.62		0.93	0.95	0.94	-0.73	0.96	-0.86	0.95	0.99	0.86	-0.94	0.97	-0.72	0.89
Cash And Equivalents	0.85	0.48	0.93	-0.98	0.92	0.98	0.92	-0.49	0.19	0.91	0.7	0.54	0.93		0.99	1.0	-0.85	0.94	-0.84	1.0	0.96	0.88	-1.0	0.95	-0.82	0.96
Common Stock	0.9	0.55	0.95	-0.99	0.94	0.98	0.94	-0.55	0.12	0.94	0.64	0.62	0.95	0.99		1.0	-0.84	0.95	-0.88	0.99	0.97	0.88	-1.0	0.96	-0.78	0.97
Property Plant Equipment	0.89	0.56	0.93	-0.99	0.92	0.98	0.92	-0.54	0.1	0.93	0.63	0.62	0.94	1.0	1.0		-0.86	0.96	-0.89	0.99	0.96	0.89	-0.99	0.95	-0.78	0.97
Short Long Term Debt Total	-0.71	-0.56	-0.71	0.89	-0.65	-0.93	-0.65	0.31	-0.04	-0.78	-0.54	-0.54	-0.73	-0.85	-0.84	-0.86		-0.88	0.79	-0.82	-0.72	-0.95	0.87	-0.86	0.83	-0.94
Other Current Liab	0.91	0.61	0.94	-0.98	0.91	0.95	0.91	-0.46	0.07	0.97	0.55	0.65	0.96	0.94	0.95	0.96	-0.88		-0.91	0.94	0.94	0.96	-0.96	0.98	-0.78	0.96
Other Liab	-0.9	-0.75	-0.8	0.93	-0.79	-0.85	-0.79	0.61	0.18	-0.91	-0.27	-0.79	-0.86	-0.84	-0.88	-0.89	0.79	-0.91		-0.84	-0.85	-0.83	0.86	-0.84	0.49	-0.91
Net Tangible Assets	0.85	0.47	0.95	-0.97	0.95	0.97	0.95	-0.5	0.21	0.92	0.72	0.53	0.95	1.0	0.99	0.99	-0.82	0.94	-0.84		0.97	0.87	-1.0	0.96	-0.81	0.95
Property Plant And Equipment Net	0.9	0.49	0.99	-0.95	0.99	0.91	0.99	-0.54	0.19	0.96	0.64	0.57	0.99	0.96	0.97	0.96	-0.72	0.94	-0.85	0.97		0.83	-0.96	0.95	-0.72	0.89
Current Deferred Revenue	0.82	0.58	0.85	-0.93	0.8	0.93	0.8	-0.33	0.09	0.9	0.56	0.58	0.86	0.88	0.88	0.89	-0.95	0.96	-0.83	0.87	0.83		-0.9	0.95	-0.85	0.94
Net Debt	-0.86	-0.51	-0.94	0.99	-0.93	-0.99	-0.93	0.5	-0.18	-0.93	-0.69	-0.57	-0.94	-1.0	-1.0	-0.99	0.87	-0.96	0.86	-1.0	-0.96	-0.9		-0.97	0.82	-0.97
Non Currrent Assets Other	0.88	0.52	0.96	-0.96	0.94	0.95	0.94	-0.42	0.19	0.96	0.66	0.56	0.97	0.95	0.96	0.95	-0.86	0.98	-0.84	0.96	0.95	0.95	-0.97		-0.85	0.94
Long Term Debt	-0.56	-0.2	-0.76	0.77	-0.71	-0.85	-0.71	0.11	-0.41	-0.69	-0.84	-0.2	-0.72	-0.82	-0.78	-0.78	0.83	-0.78	0.49	-0.81	-0.72	-0.85	0.82	-0.85		-0.79
Capital Surpluse	0.85	0.6	0.86	-0.99	0.84	0.99	0.84	-0.49	0.06	0.91	0.58	0.63	0.89	0.96	0.97	0.97	-0.94	0.96	-0.91	0.95	0.89	0.94	-0.97	0.94	-0.79

Click cells to compare fundamentals

Kits Eyecare Account Relationship Matchups

Kits Eyecare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	53.4M	54.7M	90.9M	93.9M	87.6M	61.7M
Total Current Liabilities	30.6M	34.6M	16.8M	24.4M	24.5M	22.1M
Total Stockholder Equity	6.2M	(573K)	54.8M	53.7M	51.4M	26.4M
Retained Earnings	53K	(6.5M)	(21.1M)	(25.7M)	(27.9M)	(26.5M)
Cash	3.4M	2.3M	20.5M	18.8M	16.0M	10.5M
Other Assets	5K	210K	3.6M	5.1M	5.9M	6.2M
Cash And Short Term Investments	3.4M	2.3M	20.5M	18.8M	16.0M	10.5M
Net Receivables	845K	1.1M	861K	917K	1.8M	980.3K
Long Term Debt Total	14.7M	19.1M	19.3M	15.7M	18.1M	12.6M
Liabilities And Stockholders Equity	53.4M	54.7M	90.9M	93.9M	87.6M	61.7M
Inventory	2.8M	5.8M	13.5M	16.4M	15.4M	8.8M
Other Stockholder Equity	(3.4M)	(6.9M)	1.9M	2.9M	3.0M	3.2M
Total Liab	47.2M	55.2M	36.2M	40.2M	36.2M	35.3M
Total Current Assets	7.2M	10.3M	35.7M	37.0M	34.0M	21.4M
Cash And Equivalents	3.4M	2.3M	20.5M	18.8M	21.6M	22.7M
Short Term Debt	23.3M	21.5M	3.6M	3.7M	3.7M	6.4M
Property Plant Equipment	1.1M	1.6M	10.9M	10.0M	11.5M	12.1M
Accounts Payable	5.0M	9.6M	8.4M	14.5M	12.9M	9.2M
Non Current Assets Total	46.2M	44.3M	55.2M	56.9M	53.7M	47.0M
Good Will	37.2M	36.4M	36.3M	38.8M	37.9M	34.2M
Non Current Liabilities Total	16.6M	20.7M	19.3M	15.7M	11.7M	15.4M
Capital Lease Obligations	675K	1.0M	6.9M	6.3M	5.7M	3.8M
Net Invested Capital	29.4M	20.7M	70.9M	66.9M	61.2M	45.7M
Net Working Capital	(23.4M)	(24.3M)	18.9M	12.6M	9.5M	9.9M

Pair Trading with Kits Eyecare

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kits Eyecare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kits Eyecare will appreciate offsetting losses from the drop in the long position's value.

Moving against Kits Stock

0.62

NA-PG

National Bank

Pair Corr

The ability to find closely correlated positions to Kits Eyecare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kits Eyecare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kits Eyecare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kits Eyecare to buy it.

The correlation of Kits Eyecare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kits Eyecare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kits Eyecare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Kits Eyecare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Kits Stock

Balance Sheet is a snapshot of the financial position of Kits Eyecare at a specified time, usually calculated after every quarter, six months, or one year. Kits Eyecare Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Kits Eyecare and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Kits currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Kits Net Receivables vs Selling General Administrative Analysis

Net Receivables vs Selling General Administrative

Net Receivables vs Selling General Administrative Correlation Analysis

Correlation Coefficient

Net Receivables

Selling General Administrative

Kits Eyecare fundamental ratios Correlations

Kits Eyecare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Kits Eyecare fundamental ratios Accounts

Pair Trading with Kits Eyecare

Moving against Kits Stock

Other Information on Investing in Kits Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Property Plant Equipment	+ 1.0	Cash And Equivalents
Net Tangible Assets	+ 1.0	Cash And Equivalents
Property Plant Equipment	+ 1.0	Common Stock
Total Liab	+ 0.99	Total Current Liabilities
Cash	+ 0.99	Total Stockholder Equity

Net Debt	- 1.0	Net Tangible Assets
Net Debt	- 1.0	Common Stock
Net Debt	- 1.0	Cash And Equivalents
Net Debt	- 0.99	Property Plant Equipment
Net Debt	- 0.99	Other Assets
Capital Surpluse	- 0.99	Retained Earnings